Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

hepatocellular carcinoma

  • Open Access
    Spot Scanning Proton Beam Therapy for Surgery-inaccessible Hepatocellular Carcinoma: Preliminary Results
    YUTAKA FUJIMOTO, SACHIKA SHIRAISHI, MASASHI YAMANAKA, AKIHIRO YAMANO, KAZUKI MATSUMOTO, SHINTARO SHIBA, TOSHITAKA TSUKIYAMA, MASAHIRO KOBAYASHI and KOICHI TOKUUYE
    In Vivo May 2025, 39 (3) 1654-1660; DOI: https://doi.org/10.21873/invivo.13966
  • Open Access
    Partial Splenic Embolization for Portal Hypertension Exacerbation During Atezolizumab/Bevacizumab Combination Therapy in Unresectable Hepatocellular Carcinoma
    TORU ISHIKAWA, NANAKO TERAI, RYO SATO, HIROKI NATSUI, TAKAHIRO IWASAWA, MASAHIRO OGAWA, YUJI KOBAYASHI, TOSHIFUMI SATO, JUNJI YOKOYAMA, AKIHIKO IIDUKA and TERASU HONMA
    In Vivo March 2025, 39 (2) 936-941; DOI: https://doi.org/10.21873/invivo.13898
  • Open Access
    WNT/β-catenin Signaling and CD8+ Tumor-infiltrating Lymphocytes in Tremelimumab Plus Durvalumab for Advanced Hepatocellular Carcinoma
    AKIFUMI KUWANO, KOSUKE TANAKA, JUNRO TAKAHIRA, HIDEO SUZUKI, YOSHIHIRO OHISHI and KENTA MOTOMURA
    In Vivo November 2024, 38 (6) 2774-2781; DOI: https://doi.org/10.21873/invivo.13757
  • Open Access
    Sarcopenia’s Impact Defined by Grip Strength and Muscle Mass on Post-hepatectomy Outcomes: A Multicenter Analysis
    SOTARO FUKUHARA, TSUYOSHI KOBAYASHI, MICHINORI HAMAOKA, HONMYO NARUHIKO, KOICHI OISHI, YOSUKE NAMBA, KO OSHITA, KEISO MATSUBARA, DAISUKE TAKEI, RYOSUKE NAKANO, HIROSHI SAKAI, SHINTARO KURODA, HIROYUKI TAHARA, MASAHIRO OHIRA and HIDEKI OHDAN
    In Vivo November 2024, 38 (6) 2827-2835; DOI: https://doi.org/10.21873/invivo.13763
  • Open Access
    Cytoplasmic Expression of the EGFL6 Protein Is an Independent Prognostic Factor for Shortened Patient Survival in Human Hepatocellular Carcinoma
    HUI-TING HSU, YUEH-MIN LIN, MING-TAI HSING, KUN-TU YEH, JENG-WEI LU and SHUN-FA YANG
    In Vivo September 2024, 38 (5) 2455-2463; DOI: https://doi.org/10.21873/invivo.13715
  • Open Access
    Determinants of Survival of Ablation Treatment for Portal Vein Tumor Thrombus in Patients With Hepatocellular Carcinoma
    TORU ISHIKAWA, RYO SATO, RYO JIMBO, YUJI KOBAYASHI, TOSHIFUMI SATO, AKITO IWANAGA, TOMOE SANO, JUNJI YOKOYAMA and TERASU HONMA
    In Vivo September 2024, 38 (5) 2501-2505; DOI: https://doi.org/10.21873/invivo.13721
  • Open Access
    Similar Efficacy Between Atezolizumab Plus Bevacizumab Versus Hepatic Arterial Infusion Chemotherapy For Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Retrospective Cohort Study
    AKIFUMI KUWANO, MASAYOSHI YADA, KOSUKE TANAKA, YUTA KOGA, SHIGEHIRO NAGASAWA, AKIHIDE MASUMOTO and KENTA MOTOMURA
    In Vivo July 2024, 38 (4) 1854-1858; DOI: https://doi.org/10.21873/invivo.13639
  • Open Access
    Clinicopathologic Significance of Quaking Expression in Hepatocellular Carcinoma
    SUNG-EUN KIM, CHEOL KEUN PARK, JI WON PARK, JUNG WOO LEE, JI-YOUNG CHOE and YOON AH CHO
    In Vivo July 2024, 38 (4) 2064-2073; DOI: https://doi.org/10.21873/invivo.13665
  • Open Access
    Proton-beam Therapy for Locally Advanced Hepatocellular Carcinoma With Inferior Vena Cava Tumor Thrombus: Case Report
    SHINTARO SHIBA, SACHIKA SHIRAISHI, KOICHI TOKUUYE, RYOSUKE SHIRATA and MOTOKO OMURA
    In Vivo July 2024, 38 (4) 2080-2084; DOI: https://doi.org/10.21873/invivo.13667
  • Open Access
    Correlation Between Low Cytoplasmic Expression of XBP1 and the Likelihood of Surviving Hepatocellular Carcinoma
    HUI-TING HSU, YUEH-MIN LIN, MING-TAI HSING, KUN-TU YEH, JENG-WEI LU and SHUN-FA YANG
    In Vivo May 2024, 38 (3) 1316-1324; DOI: https://doi.org/10.21873/invivo.13571

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
In Vivo

© 2025 In Vivo

Powered by HighWire